Compugen (CGEN) Free Cash Flow (2009 - 2010)
Compugen (CGEN) posted quarterly Free Cash Flow of -$919000.0 for Q4 2010, up 57.28% year-over-year from -$584324.3 in Q4 2009, and down 141.84% on a QoQ basis from -$380000.0 in Q3 2010.
Powered by 
Analysis
Compugen (CGEN) Free Cash Flow (2009 - 2010) Analysis & Trends
Compugen has reported Free Cash Flow for 2 years, with the latest figure at -$919000.0 in Q4 2010.
- Free Cash Flow for Q4 2010 came in at -$919000.0, up 57.28% year-over-year; the trailing twelve-month figure through Sep 2011 was -$919000.0 (up 63.69% YoY), and the FY2025 annual result was $31.3 million, down 36.69% from the prior year.
- Free Cash Flow fell to -$919000.0 in Q4 2010, from -$380000.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at -$380000.0 in Q3 2010 and troughed at -$2.2 million in Q4 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Compugen | 241.50 Mn | 155.89 Mn | -92,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | -827,000.00 |
| Sep 30, 2010 | -380,000.00 |
| Dec 31, 2009 | -2.06 Mn |
| Sep 30, 2009 | -942,000.00 |